Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Privia Health Group Inc has a consensus price target of $31.5 based on the ratings of 28 analysts. The high is $51 issued by Guggenheim on August 12, 2022. The low is $20 issued by Evercore ISI Group on July 9, 2024. The 3 most-recent analyst ratings were released by JP Morgan, Barclays, and JMP Securities on May 28, 2025, May 27, 2025, and April 28, 2025, respectively. With an average price target of $28.33 between JP Morgan, Barclays, and JMP Securities, there's an implied 28.79% upside for Privia Health Group Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/28/2025 | Buy Now | 45.45% | JP Morgan | Lisa Gill55% | $29 → $32 | Maintains | Overweight | Get Alert |
05/27/2025 | Buy Now | 9.09% | Barclays | Andrew Mok57% | $23 → $24 | Maintains | Equal-Weight | Get Alert |
04/28/2025 | Buy Now | 31.82% | JMP Securities | Constantine Davides42% | $29 → $29 | Reiterates | Market Outperform → Market Outperform | Get Alert |
04/15/2025 | Buy Now | 18.18% | Baird | Michael Ha37% | $24 → $26 | Maintains | Outperform | Get Alert |
04/10/2025 | Buy Now | 4.55% | Barclays | Andrew Mok57% | $21 → $23 | Maintains | Equal-Weight | Get Alert |
04/10/2025 | Buy Now | 27.27% | Truist Securities | Jailendra Singh38% | $27 → $28 | Maintains | Buy | Get Alert |
04/10/2025 | Buy Now | 36.36% | Needham | Matthew Sheerin75% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
03/21/2025 | Buy Now | 36.36% | Needham | Ryan MacDonald63% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
02/28/2025 | Buy Now | 31.82% | Citizens Capital Markets | Constantine Davides42% | $26 → $29 | Maintains | Market Outperform | Get Alert |
02/28/2025 | Buy Now | 36.36% | Canaccord Genuity | Richard Close46% | $29 → $30 | Maintains | Buy | Get Alert |
02/28/2025 | Buy Now | 81.82% | Piper Sandler | Sean Wieland44% | $25 → $40 | Maintains | Overweight | Get Alert |
02/28/2025 | Buy Now | 36.36% | Needham | Ryan MacDonald63% | $25 → $30 | Maintains | Buy | Get Alert |
02/14/2025 | Buy Now | 18.18% | JMP Securities | Constantine Davides42% | $26 → $26 | Maintains | Market Outperform | Get Alert |
01/15/2025 | Buy Now | 13.64% | Needham | Ryan MacDonald63% | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
01/10/2025 | Buy Now | 13.64% | Needham | Matthew Sheerin75% | → $25 | Initiates | → Buy | Get Alert |
01/07/2025 | Buy Now | 18.18% | Stephens & Co. | Jeff Garro37% | $26 → $26 | Reiterates | Overweight → Overweight | Get Alert |
01/02/2025 | Buy Now | 18.18% | Stephens & Co. | Jeff Garro37% | $26 → $26 | Reiterates | Overweight → Overweight | Get Alert |
12/16/2024 | Buy Now | 13.64% | Macquarie | Tao Qiu52% | → $25 | Initiates | → Outperform | Get Alert |
11/29/2024 | Buy Now | 27.27% | JP Morgan | Lisa Gill55% | $27 → $28 | Maintains | Overweight | Get Alert |
11/08/2024 | Buy Now | -4.55% | Barclays | Andrew Mok57% | $19 → $21 | Maintains | Equal-Weight | Get Alert |
11/08/2024 | Buy Now | 22.73% | Truist Securities | Jailendra Singh38% | $24 → $27 | Maintains | Buy | Get Alert |
10/11/2024 | Buy Now | 4.55% | Keybanc | Matthew Gillmor65% | → $23 | Initiates | → Overweight | Get Alert |
08/26/2024 | Buy Now | 9.09% | Baird | Michael Ha37% | $23 → $24 | Maintains | Outperform | Get Alert |
08/14/2024 | Buy Now | 27.27% | RBC Capital | Sean Dodge47% | $28 → $28 | Reiterates | Outperform → Outperform | Get Alert |
07/09/2024 | Buy Now | -9.09% | Evercore ISI Group | Elizabeth Anderson48% | $23 → $20 | Maintains | Outperform | Get Alert |
05/30/2024 | Buy Now | 4.55% | Baird | Michael Ha37% | → $23 | Initiates | → Outperform | Get Alert |
05/20/2024 | Buy Now | -13.64% | Barclays | Andrew Mok57% | $22 → $19 | Maintains | Equal-Weight | Get Alert |
05/15/2024 | Buy Now | 9.09% | Truist Securities | Jailendra Singh38% | $28 → $24 | Maintains | Buy | Get Alert |
05/10/2024 | Buy Now | 18.18% | Canaccord Genuity | Richard Close46% | $37 → $26 | Maintains | Buy | Get Alert |
05/01/2024 | Buy Now | 9.09% | Stifel | Craig Jones46% | $28 → $24 | Maintains | Buy | Get Alert |
04/22/2024 | Buy Now | 13.64% | Citigroup | Daniel Grosslight44% | → $25 | Initiates | → Buy | Get Alert |
03/19/2024 | Buy Now | 68.18% | Canaccord Genuity | Richard Close46% | $41 → $37 | Maintains | Buy | Get Alert |
03/06/2024 | Buy Now | 36.36% | JP Morgan | Lisa Gill55% | $38 → $30 | Maintains | Overweight | Get Alert |
03/06/2024 | Buy Now | — | Barclays | Andrew Mok57% | → $22 | Initiates | → Equal-Weight | Get Alert |
03/01/2024 | Buy Now | 31.82% | UBS | Andrew Mok57% | $31 → $29 | Maintains | Buy | Get Alert |
03/01/2024 | Buy Now | 18.18% | TD Cowen | Gary Taylor58% | $30 → $26 | Maintains | Outperform | Get Alert |
02/29/2024 | Buy Now | 27.27% | Truist Securities | Jailendra Singh38% | $32 → $28 | Maintains | Buy | Get Alert |
02/28/2024 | Buy Now | 13.64% | Evercore ISI Group | Elizabeth Anderson48% | $26 → $25 | Maintains | Outperform | Get Alert |
02/22/2024 | Buy Now | -4.55% | B of A Securities | Adam Ron45% | $27 → $21 | Downgrade | Buy → Neutral | Get Alert |
12/06/2023 | Buy Now | 22.73% | JMP Securities | Constantine Davides42% | → $27 | Initiates | → Market Outperform | Get Alert |
11/17/2023 | Buy Now | 72.73% | JP Morgan | Lisa Gill55% | $43 → $38 | Maintains | Overweight | Get Alert |
08/18/2023 | Buy Now | 45.45% | UBS | Andrew Mok57% | $35 → $32 | Maintains | Buy | Get Alert |
08/15/2023 | Buy Now | 59.09% | TD Cowen | Gary Taylor58% | $44 → $35 | Maintains | Outperform | Get Alert |
06/22/2023 | Buy Now | 86.36% | Credit Suisse | Jonathan Yon51% | → $41 | Reiterates | Outperform → Outperform | Get Alert |
06/13/2023 | Buy Now | 54.55% | Evercore ISI Group | Elizabeth Anderson48% | → $34 | Initiates | → Outperform | Get Alert |
05/08/2023 | Buy Now | 86.36% | Credit Suisse | Jonathan Yon51% | → $41 | Reiterates | → Outperform | Get Alert |
04/12/2023 | Buy Now | 50% | Stephens & Co. | Jeff Garro37% | → $33 | Initiates | → Overweight | Get Alert |
03/10/2023 | Buy Now | 63.64% | RBC Capital | Sean Dodge47% | → $36 | Initiates | → Outperform | Get Alert |
03/07/2023 | Buy Now | 86.36% | Credit Suisse | Jonathan Yong65% | → $41 | Reiterates | → Outperform | Get Alert |
02/03/2023 | Buy Now | 45.45% | Goldman Sachs | Jamie Perse63% | → $32 | Initiates | → Buy | Get Alert |
12/09/2022 | Buy Now | 27.27% | Stifel | Craig Jones46% | → $28 | Initiates | → Buy | Get Alert |
12/08/2022 | Buy Now | 36.36% | UBS | Andrew Mok57% | → $30 | Initiates | → Buy | Get Alert |
11/11/2022 | Buy Now | 95.45% | Canaccord Genuity | Richard Close46% | $50 → $43 | Maintains | Buy | Get Alert |
11/11/2022 | Buy Now | 77.27% | SVB Leerink | Whit Mayo67% | $46 → $39 | Maintains | Outperform | Get Alert |
09/07/2022 | Buy Now | 145.45% | Truist Securities | Jailendra Singh38% | $48 → $54 | Assumes | → Buy | Get Alert |
08/25/2022 | Buy Now | 127.27% | Canaccord Genuity | Richard Close46% | $45 → $50 | Maintains | Buy | Get Alert |
08/12/2022 | Buy Now | 118.18% | Truist Securities | David Macdonald65% | $40 → $48 | Maintains | Buy | Get Alert |
08/12/2022 | Buy Now | 131.82% | Guggenheim | Sandy Draper73% | $36 → $51 | Maintains | Buy | Get Alert |
08/12/2022 | Buy Now | 86.36% | Credit Suisse | Nick Giovacchini49% | $33 → $41 | Maintains | Outperform | Get Alert |
08/12/2022 | Buy Now | 100% | Cowen & Co. | Gary Taylor58% | $35 → $44 | Maintains | Outperform | Get Alert |
08/12/2022 | Buy Now | 109.09% | SVB Leerink | Whit Mayo67% | $33 → $46 | Maintains | Outperform | Get Alert |
07/14/2022 | Buy Now | 81.82% | Truist Securities | David Macdonald65% | $36 → $40 | Maintains | Buy | Get Alert |
The latest price target for Privia Health Gr (NASDAQ:PRVA) was reported by JP Morgan on May 28, 2025. The analyst firm set a price target for $32.00 expecting PRVA to rise to within 12 months (a possible 45.45% upside). 25 analyst firms have reported ratings in the last year.
The latest analyst rating for Privia Health Gr (NASDAQ:PRVA) was provided by JP Morgan, and Privia Health Gr maintained their overweight rating.
There is no last upgrade for Privia Health Gr
The last downgrade for Privia Health Group Inc happened on February 22, 2024 when B of A Securities changed their price target from $27 to $21 for Privia Health Group Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Privia Health Gr, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Privia Health Gr was filed on May 28, 2025 so you should expect the next rating to be made available sometime around May 28, 2026.
While ratings are subjective and will change, the latest Privia Health Gr (PRVA) rating was a maintained with a price target of $29.00 to $32.00. The current price Privia Health Gr (PRVA) is trading at is $22.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.